Medication Class Effects on Visit-to-Visit Variability of Blood Pressure Measurements: Analysis of Electronic Health Record Data in the "Real World"

被引:26
作者
Smith, Timothy R. [1 ]
Drozda, Joseph P., Jr. [1 ]
Vanslette, Jeffrey A. [1 ]
Hoeffken, Amanda S. [1 ]
Nicholson, Robert A. [1 ]
机构
[1] Mercy Hlth, Ctr Innovat Care, Chesterfield, MO USA
基金
美国国家卫生研究院;
关键词
STROKE; REPRODUCIBILITY; HYPERTENSION; MORTALITY; DISEASE; RISK;
D O I
10.1111/jch.12165
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Blood pressure (BP) visit-to-visit variability (VVV) influences the risk of vascular events and mortality. Research has suggested that antihypertensive medication classes may differentially impact VVV. This study evaluated whether antihypertensive medication class differentially impacted BP VVV among hypertensive individuals in a clinical, real-world setting as well as the association between VVV and patient characteristics. Clinical observational data were extracted for adults (mean age, 63; 56% female, 86% Caucasian) with hypertension from the Mercy EpicCare EHR-Derived Database (MEDD) (n=183,374) who had at least 4 outpatient visits with BP readings. A multilevel mixed model for change over time estimated between- and within-subject effects on the absolute real VVV of systolic BP. Diuretics significantly lowered VVV (=-0.32[-0.39 to-0.25]) and -/-blockers resulted in the highest VVV (=0.89 [0.77-1.00]). Being older, female, and having a higher systolic BP and certain comorbid conditions significantly raised VVV (P<.001). The findings from the MEDD were consistent in general with other research on BP VVV. However, the magnitude of effect of antihypertensive medication class and patient characteristics was relatively low (<10% of the BP VVV variance for any one variable). More research is needed to evaluate the extent to which the class of antihypertensive medication class impacts BP VVV in the outpatient setting.
引用
收藏
页码:655 / 662
页数:8
相关论文
共 23 条
[1]  
[Anonymous], 2011, PHYS QUALITY REPORTI
[2]  
[Anonymous], 2005, Methodology, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86, 10.1027/1614-1881.1.3.86, DOI 10.1027/1614-1881.1.3.86]
[3]  
[Anonymous], 2008, SAS 9 2
[4]   Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].
Dahlöf, B ;
Sever, PS ;
Poulter, NR ;
Wedel, H ;
Beevers, DG ;
Caulfield, M ;
Collins, R ;
Kjeldsen, SE ;
Kristinsson, A ;
McInnes, GT ;
Mehlsen, J ;
Nieminen, M ;
O'Brien, E ;
Östergren, J .
LANCET, 2005, 366 (9489) :895-906
[5]   Reproducibility of Measures of Visit-to-Visit Variability in Blood Pressure after Transient Ischaemic Attack or Minor Stroke [J].
Howard, S. C. ;
Rothwell, P. M. .
CEREBROVASCULAR DISEASES, 2009, 28 (04) :331-340
[6]   Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure [J].
Klungel, OH ;
de Boer, A ;
Paes, AHP ;
Nagelkerke, NJD ;
Seidell, JC ;
Bakker, A .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (11) :1158-1163
[7]   Global burden of blood-pressure-related disease, 2001 [J].
Lawes, Carlene M. M. ;
Vander Hoorn, Stephen ;
Rodgers, Anthony .
LANCET, 2008, 371 (9623) :1513-1518
[8]  
Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
[9]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .1. PROLONGED DIFFERENCES IN BLOOD-PRESSURE - PROSPECTIVE OBSERVATIONAL STUDIES CORRECTED FOR THE REGRESSION DILUTION BIAS [J].
MACMAHON, S ;
PETO, R ;
CUTLER, J ;
COLLINS, R ;
SORLIE, P ;
NEATON, J ;
ABBOTT, R ;
GODWIN, J ;
DYER, A ;
STAMLER, J .
LANCET, 1990, 335 (8692) :765-774
[10]   When measurements are misleading: modelling the effects of blood pressure misclassification in English population [J].
Marshall, T .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7445) :933-933